Neurodegenerative Diseases

Scope & Guideline

Innovating therapeutic interventions for neurological health.

Introduction

Welcome to the Neurodegenerative Diseases information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Neurodegenerative Diseases, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1660-2854
PublisherKARGER
Support Open AccessNo
CountrySwitzerland
TypeJournal
Convergefrom 2004 to 2024
AbbreviationNEURODEGENER DIS / Neurodegener. Dis.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND

Aims and Scopes

The journal 'Neurodegenerative Diseases' focuses on advancing the understanding of neurodegenerative disorders through a multidisciplinary approach, integrating clinical, epidemiological, genetic, and neurobiological research.
  1. Clinical Research and Epidemiology:
    The journal emphasizes studies that investigate the clinical aspects of neurodegenerative diseases, including risk factors, progression, and patient outcomes, often through cohort studies and clinical trials.
  2. Neuroimaging and Biomarkers:
    A significant focus is placed on neuroimaging techniques and the identification of biomarkers that aid in the diagnosis and monitoring of neurodegenerative diseases, contributing to personalized medicine.
  3. Molecular and Genetic Mechanisms:
    The exploration of genetic underpinnings and molecular pathways involved in neurodegeneration is a core area, aiming to uncover potential therapeutic targets.
  4. Innovative Therapeutic Approaches:
    The journal highlights novel therapeutic strategies, including pharmacological interventions, stem cell therapy, and lifestyle modifications, to mitigate disease progression.
  5. Patient-Centered Research:
    Research addressing the quality of life, psychosocial aspects, and caregiver challenges related to neurodegenerative diseases is also a vital area of focus.
Recent publications have indicated several emerging themes within the journal that reflect current trends in neurodegenerative disease research, highlighting innovative methodologies and new areas of inquiry.
  1. Machine Learning and Data Analytics:
    There is a growing trend towards utilizing machine learning and advanced data analytics to predict disease progression and outcomes, showcasing the intersection of technology and healthcare.
  2. Gut-Brain Axis Research:
    An emerging focus on the relationship between gut microbiota and neurodegenerative diseases is evident, emphasizing the importance of the gut-brain axis in the pathophysiology of these disorders.
  3. Multimodal Approaches to Diagnosis:
    The integration of multiple diagnostic modalities, including neuroimaging, biomarkers, and cognitive assessments, is increasingly highlighted to improve diagnostic accuracy and patient stratification.
  4. Neuroinflammation and Immune Response:
    Research on the role of neuroinflammation and the immune response in neurodegenerative diseases is gaining traction, reflecting a shift towards understanding the complex interactions between the immune system and neurodegeneration.
  5. Telehealth and Remote Assessments:
    The rise of telehealth and digital health solutions for remote assessment and management of neurodegenerative diseases has become a prominent theme, particularly in light of the COVID-19 pandemic.

Declining or Waning

Over recent years, certain themes within the journal have shown a decline in prominence or frequency of publication, reflecting shifts in research priorities and emerging interests.
  1. Traditional Pharmacotherapy:
    There appears to be a waning interest in traditional pharmacotherapy approaches, with fewer studies focusing solely on established drugs, as researchers increasingly explore innovative treatments and personalized medicine.
  2. Basic Science Models:
    Research utilizing basic animal models without translational relevance to human conditions has decreased, as the journal's focus shifts towards studies that provide direct implications for human health and disease management.
  3. Epidemiological Studies in Isolated Populations:
    While epidemiological research remains important, studies focusing on isolated or less diverse populations are becoming less frequent, potentially due to a growing emphasis on more globally relevant findings.

Similar Journals

LANCET NEUROLOGY

Your Gateway to Neurology's Cutting Edge
Publisher: ELSEVIER SCIENCE INCISSN: 1474-4422Frequency: 12 issues/year

The Lancet Neurology is a premier academic journal published by Elsevier Science Inc, specializing in the field of neurology. With a robust impact factor that signifies its authoritative presence, it consistently ranks in the Q1 category for clinical neurology according to the 2023 standards, positioning itself as the leading journal in its domain, ranking #1 out of 400 in Scopus' neurology rankings and placing in the 99th percentile. Since its establishment in 2002, it has provided a vital platform for disseminating innovative research and clinical advances related to neurological disorders. The journal’s precise focus includes cutting-edge studies on neurodegenerative diseases, stroke, epilepsy, and neuroimaging, which are essential for advancing clinical practice and improving patient outcomes. While it does not offer open access, readers can find high-impact research published monthly, making it indispensable for practitioners, researchers, and students eager to stay at the forefront of neurological science.

Journal of Inflammation Research

Fostering Collaboration in the Fight Against Inflammation
Publisher: DOVE MEDICAL PRESS LTDISSN: Frequency: 1 issue/year

Journal of Inflammation Research, published by Dove Medical Press Ltd, is a premier open-access journal dedicated to advancing the field of immunology and allergy, with a particular focus on the biological mechanisms underlying inflammation. Since its inception in 2008, this journal has provided a vital platform for researchers to share their findings and foster collaboration within the global scientific community. With an impressive 2023 impact factor placing it in the Q2 category for both Immunology and Immunology and Allergy, the journal has consistently maintained its relevance and high academic standards, ranking #100 in Medicine (Immunology and Allergy) and #118 in Immunology (Immunology and Microbiology) according to Scopus metrics. The E-ISSN 1178-7031 allows for easy access to a plethora of pioneering research articles, reviews, and clinical studies that address contemporary issues in inflammation and immunity. As a leading resource for researchers, professionals, and students alike, Journal of Inflammation Research is committed to facilitating the dissemination of groundbreaking discoveries that contribute to improved therapeutic strategies and health outcomes.

MOLECULAR MEDICINE

Connecting Science and Healthcare for a Better Future
Publisher: SPRINGERISSN: 1076-1551Frequency: 1 issue/year

MOLECULAR MEDICINE, published by SPRINGER, is a leading scholarly journal dedicated to advancing the fields of genetics and molecular biology with a focus on clinical applications. Since its inception in 1994, it has evolved to become a pivotal platform for disseminating innovative research findings, achieving a remarkable Q1 ranking in multiple categories, including Genetics, Molecular Biology, and Molecular Medicine as of 2023. Featuring an Open Access model since 2000, the journal ensures that cutting-edge research is freely available to the global scientific community, facilitating collaboration and knowledge exchange. With a commitment to high-quality peer-reviewed content, MOLECULAR MEDICINE serves as an essential resource for researchers, healthcare professionals, and students seeking to stay at the forefront of molecular research and its implications for medical science. For those interested in contributing to or accessing vital research in this dynamic field, MOLECULAR MEDICINE stands out as a premier choice.

Journal of Huntingtons Disease

Exploring Solutions for Neurodegenerative Disorders
Publisher: IOS PRESSISSN: 1879-6397Frequency: 4 issues/year

The Journal of Huntington's Disease is a premier academic publication dedicated to advancing the understanding of Huntington's disease and related neurodegenerative disorders. Published by IOS PRESS, this journal has established itself as a vital resource for the scientific community, with an impressive impact factor reflecting its rigorous standards and influential research contributions. With a converged publication period from 2012 to 2024, the journal holds esteemed rankings in the 2023 Q2 category for Cellular and Molecular Neuroscience and Q1 for Neurology (clinical) on Scopus, highlighting its relevance and authority within these critical fields. Researchers, professionals, and students will find a wealth of peer-reviewed articles that examine the molecular mechanisms, clinical manifestations, and therapeutic strategies related to Huntington’s disease. Although not an open-access journal, it provides various access options to ensure that critical research reaches its intended audience. As an essential platform for disseminating groundbreaking findings in neurology and neuroscience, the Journal of Huntington's Disease plays a crucial role in shaping the future of research and treatment strategies related to this devastating condition.

Neurology and Clinical Neuroscience

Bridging research and clinical excellence in neuroscience.
Publisher: WILEYISSN: 2049-4173Frequency: 6 issues/year

Neurology and Clinical Neuroscience, published by WILEY, is a pivotal peer-reviewed journal dedicated to advancing knowledge in the fields of neurology and clinical neuroscience. With an ISSN of 2049-4173, it encompasses a diverse range of topics related to neurological disorders, offering a platform for groundbreaking research and clinical practices. Although the journal does not currently operate under an open access model, it aims to foster an inclusive academic environment by providing high-quality content that is accessible to both specialists and general practitioners in the medical community. Despite its relatively recent establishment from 2013 to 2024, the journal has gained recognition with Scopus rankings highlighting its role in clinical neurology and neuroscience spheres. It serves as an essential resource for researchers, professionals, and students seeking to expand their understanding and engage in current discussions surrounding neurological health and diseases.

Translational Neurodegeneration

Driving Breakthroughs in Neurodegenerative Disease Treatment
Publisher: BMCISSN: 2047-9158Frequency: 1 issue/year

Translational Neurodegeneration, an esteemed journal in the field of neuroscience, is published by BMC and has been an open access platform since 2012, delivering high-quality research from its base in the United Kingdom. With an impressive impact factor reflecting its significant contributions, this journal focuses on critical advancements in cellular and molecular neuroscience, cognitive neuroscience, and clinical neurology, boasting a Q1 ranking across all these categories as of 2023. Researchers and professionals benefit from its extensive reach, characterized by exceptional Scopus rankings that place it in the top percentile of its field. The journal serves as a vital resource for academics and healthcare practitioners alike, aiming to bridge the gap between laboratory discoveries and clinical applications, thereby enhancing understanding and treatment of neurodegenerative diseases. With its commitment to open access, Translational Neurodegeneration ensures that its published research is accessible to a global audience, promoting collaboration and knowledge exchange within the scientific community.

NEUROLOGY

Advancing neurological science for a healthier tomorrow.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0028-3878Frequency: 48 issues/year

NEUROLOGY, published by Lippincott Williams & Wilkins, stands as a premier journal in the field of neurology, holding an esteemed Q1 category ranking in clinical neurology as of 2023. Established in 1951, this journal has been a critical resource for the dissemination of cutting-edge research and clinical advancements, with an impressive Scopus rank of 24 out of 400, placing it in the 94th percentile among its peers. NEUROLOGY serves as a vital platform for neurologists, researchers, and medical professionals seeking to stay abreast of the latest findings and innovations in the treatment and understanding of neurological disorders. With its rigorous peer-review process and commitment to excellence, NEUROLOGY remains essential reading for all individuals dedicated to advancing the science and practice of neurology, contributing significantly to the ongoing dialogue in this vital area of medicine.

JAMA Neurology

Advancing Neurological Insights for Tomorrow's Treatments
Publisher: AMER MEDICAL ASSOCISSN: 2168-6149Frequency: 12 issues/year

JAMA Neurology is a leading peer-reviewed journal published by the American Medical Association, focused on advancing the understanding and treatment of neurological disorders. With an impressive impact factor and ranked in the 99th percentile among clinical neurology journals, this publication is recognized as Q1 in its category for 2023, highlighting its significance in the field. Since its inception, the journal has provided a platform for high-quality research, clinical trials, and reviews that inform both clinicians and researchers. Operating from its headquarters in Chicago, Illinois, JAMA Neurology offers rich insights into the latest advancements in neurology, featuring articles that span a wide range of topics including neurodegenerative diseases, stroke, epilepsy, and neurocritical care. Researchers and professionals are encouraged to access the journal’s content freely, as it employs open access options to promote the dissemination of critical knowledge. As a critical resource in the field of neurology, JAMA Neurology is essential for anyone involved in this dynamic and rapidly evolving specialty.

npj Parkinsons Disease

Advancing the frontiers of Parkinson's research.
Publisher: NATURE PORTFOLIOISSN: Frequency: 1 issue/year

npj Parkinsons Disease is a leading open-access journal dedicated to advancing research in the field of Parkinson's disease and related neurodegenerative disorders. Published by NATURE PORTFOLIO, this journal has been on the forefront of scientific inquiry since its inception in 2015, providing a high-quality platform for the dissemination of groundbreaking research. The journal's reputation is underscored by its impressive Q1 rankings in Cellular and Molecular Neuroscience and Neurology categories, as well as its commendable positions in Scopus rankings, placing it within the top echelons of neuroscience and clinical neurology research. With its focus on innovative methodologies and translational studies, npj Parkinsons Disease aims to foster collaboration among researchers, clinicians, and healthcare professionals, ultimately contributing to the improved understanding and treatment of Parkinson's disease. Researchers, professionals, and students are encouraged to explore its rich repository of knowledge, accessible freely since its launch, to stay abreast of the latest developments in this critical area of neuroscience.

JOURNAL OF CLINICAL NEUROSCIENCE

Pioneering Research for a Brighter Neurological Future
Publisher: ELSEVIER SCI LTDISSN: 0967-5868Frequency: 12 issues/year

JOURNAL OF CLINICAL NEUROSCIENCE is an esteemed publication dedicated to advancing the field of neurology and related medical disciplines. Published by ELSEVIER SCI LTD, this journal serves as a vital resource for researchers, clinicians, and educators, providing a platform for the dissemination of high-quality research findings since its inception in 1994. With a noteworthy impact factor and ranked within the Q2 and Q3 categories across various medical specialties, including neurology and surgery, the journal positions itself at the forefront of clinical neuroscience. Although it operates under a traditional subscription model, the journal’s commitment to publishing rigorous scientific work ensures that it remains an integral reference for anyone involved in the diagnosis, treatment, and understanding of neurological disorders. Readers can access a diverse array of articles that not only highlight current research trends but also foster the exchange of innovative ideas in clinical practice.